These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38360242)

  • 21. Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico.
    Jhong CH; Riyaphan J; Lin SH; Chia YC; Weng CF
    Biofactors; 2015; 41(4):242-51. PubMed ID: 26154585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
    Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
    Ullah H; Khan S; Rahim F; Taha M; Iqbal R; Sarfraz M; Shah SAA; Sajid M; Awad MF; Omran A; Albalawi MA; Abdelaziz MA; Al Areefy A; Jafri I
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular dynamics simulations reveal the inhibitory mechanism of Withanolide A against α-glucosidase and α-amylase.
    Oyewusi HA; Wu YS; Safi SZ; Wahab RA; Hatta MHM; Batumalaie K
    J Biomol Struct Dyn; 2023; 41(13):6203-6218. PubMed ID: 35904027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vitro and Molecular Docking Evaluation of the Anticholinesterase and Antidiabetic Effects of Compounds from
    Feunaing RT; Tamfu AN; Gbaweng AJY; Kucukaydin S; Tchamgoue J; Lannang AM; Lenta BN; Kouam SF; Duru ME; Anouar EH; Talla E; Dinica RM
    Molecules; 2024 May; 29(11):. PubMed ID: 38893333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents.
    Acar Çevik U; Celik I; Paşayeva L; Fatullayev H; Bostancı HE; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2023 May; 356(5):e2200663. PubMed ID: 36760015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel acyl hydrazide derivatives of polyhydroquinoline as potent anti-diabetic and anti-glycating agents: Synthesis, in vitro α-amylase, α-glucosidase inhibition and anti-glycating activity with molecular docking insights.
    Ur Rahman S; Alam A; Parveen Z; Zainab ; Assad M; Adnan Ali Shah S; Rafiq H; Ayaz M; Latif A; Naveed Umar M; Ali M; Ahmad M
    Bioorg Chem; 2024 Sep; 150():107501. PubMed ID: 38865858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regioselective syntheses of 2-oxopyridine carbonitrile derivatives and evaluation for antihyperglycemic and antioxidant potential.
    Saleem F; Haider M; Khan KM; Özil M; Baltaş N; Ul-Haq Z; Qureshi U; Salar U; Taha M; Hameed S; Ullah N
    Int J Biol Macromol; 2023 Jun; 241():124589. PubMed ID: 37116840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-Amylase and Alpha-Glucosidase Enzyme Inhibition and Antioxidant Potential of 3-Oxolupenal and Katononic Acid Isolated from
    Alqahtani AS; Hidayathulla S; Rehman MT; ElGamal AA; Al-Massarani S; Razmovski-Naumovski V; Alqahtani MS; El Dib RA; AlAjmi MF
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905962
    [No Abstract]   [Full Text] [Related]  

  • 30. In Vitro Evaluation of α-amylase and α-glucosidase Inhibition of 2,3-Epoxyprocyanidin C1 and Other Constituents from
    Feunaing RT; Tamfu AN; Gbaweng AJY; Mekontso Magnibou L; Ntchapda F; Henoumont C; Laurent S; Talla E; Dinica RM
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indenoquinoxaline-phenylacrylohydrazide hybrids as promising drug candidates for the treatment of type 2 diabetes: In vitro and in silico evaluation of enzyme inhibition and antioxidant activity.
    Hameed S; Saleem F; Özil M; Baltaş N; Salar U; Ashraf S; Ul-Haq Z; Taha M; Khan KM
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):129517. PubMed ID: 38266833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facile synthesis and
    Punia R; Mor S; Khatri M; Kumar D; Das PP; Jindal DK; Kumar A; Selvaraj P; Kumar R; Mohil R; Jakhar K
    Future Med Chem; 2024; 16(10):999-1027. PubMed ID: 38910576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus.
    Thabet HK; Abusaif MS; Imran M; Helal MH; Alaqel SI; Alshehri A; Mohd AA; Ammar YA; Ragab A
    Comput Biol Chem; 2024 Aug; 111():108097. PubMed ID: 38772048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated compounds from Dracaena angustifolia Roxb and acarbose synergistically/additively inhibit α-glucosidase and α-amylase: an in vitro study.
    Yi J; Zhao T; Zhang Y; Tan Y; Han X; Tang Y; Chen G
    BMC Complement Med Ther; 2022 Jul; 22(1):177. PubMed ID: 35780093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrano[2,3-b]chromone derivatives as novel dual inhibitors of α-glucosidase and α-amylase: Design, synthesis, biological evaluation, and in silico studies.
    Farzaneh E; Mohammadi M; Raymand P; Noori M; Golestani S; Ranjbar S; Ghasemi Y; Mohammadi-Khanaposhtani M; Asadi M; Nasli Esfahani E; Rastegar H; Larijani B; Mahdavi M; Taslimi P
    Bioorg Chem; 2024 Apr; 145():107207. PubMed ID: 38402795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study.
    Hussain R; Iqbal S; Shah M; Rehman W; Khan S; Rasheed L; Rahim F; Dera AA; Kehili S; Elkaeed EB; Awwad NS; Bajaber MA; Alahmdi MI; Alrbyawi H; Alsaab HO
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of α-amylase and α-glucosidase inhibitory potential of Zea mays Linnaeus (Poaceae), Stigma maydis aqueous extract: An in vitro assessment.
    Sabiu S; O'Neill FH; Ashafa AOT
    J Ethnopharmacol; 2016 May; 183():1-8. PubMed ID: 26902829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic effect of potential alpha-amylase inhibitors from Egyptian propolis with acarbose using in silico and in vitro combination analysis.
    Nada AA; Metwally AM; Asaad AM; Celik I; Ibrahim RS; Eldin SMS
    BMC Complement Med Ther; 2024 Jan; 24(1):65. PubMed ID: 38291462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feruloyl Sucrose Esters: Potent and Selective Inhibitors of α-glucosidase and α-amylase.
    Devaraj S; Yip YM; Panda P; Ong LL; Wong PWK; Zhang D; Ali Y; Judeh Z
    Curr Med Chem; 2022; 29(9):1606-1621. PubMed ID: 34455958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.